TScan Therapeutics Inc.
(TCRX)
undefined
undefined%
At close: undefined
2.85
-0.70%
After-hours Dec 13, 2024, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 133.36M | 120.03M | 161.41M | 34.79M | 41.76M |
| Short-Term Investments | 58.69M | - | - | - | - |
| Long-Term Investments | - | 5.04M | 5.20M | 761.00K | 595.00K |
| Other Long-Term Assets | 6.68M | 4.83M | - | - | - |
| Receivables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other Current Assets | 2.19M | 4.10M | 8.50M | 1.65M | 615.00K |
| Total Current Assets | 194.24M | 120.03M | 165.65M | 36.45M | 42.38M |
| Property-Plant & Equipment | 71.23M | 69.20M | 17.26M | 12.53M | 6.41M |
| Goodwill & Intangibles | - | - | - | - | - |
| Total Long-Term Assets | 77.91M | 79.06M | 22.45M | 13.29M | 7.00M |
| Total Assets | 272.15M | 199.09M | 188.11M | 49.74M | 49.38M |
| Account Payables | 2.37M | 2.91M | 1.76M | 2.91M | 1.01M |
| Deferred Revenue | 10.14M | 3.87M | 11.41M | 10.63M | 912.00K |
| Short-Term Debt | 9.84M | 7.36M | 3.30M | 1.42M | 443.00K |
| Other Current Liabilities | 7.47M | 3.16M | 4.87M | 2.49M | 943.00K |
| Total Current Liabilities | 29.82M | 17.30M | 21.34M | 17.45M | 2.40M |
| Long-Term Debt | 85.84M | 82.30M | 4.39M | -53.66M | 4.44M |
| Other Long-Term Liabilities | - | 49.00K | 97.00K | -59.44M | 59.68M |
| Total Long-Term Liabilities | 91.46M | 82.35M | 5.99M | 74.75M | 64.13M |
| Total Liabilities | 121.28M | 99.66M | 27.33M | 92.20M | 66.52M |
| Total Debt | 92.43M | 85.98M | 6.04M | 7.43M | 4.89M |
| Common Stock | 5.00K | 3.00K | 3.00K | 1K | - |
| Retained Earnings | -247.60M | -158.38M | -92.16M | -43.53M | -17.41M |
| Comprehensive Income | - | -0.00 | -188.11M | -59.68M | -0.00 |
| Shareholders Equity | 150.87M | 99.43M | 160.78M | -42.46M | -17.14M |
| Total Investments | 58.69M | 5.04M | 5.20M | 761.00K | 595.00K |